Topic 1 - Molecules, Transport and Health

Water is polar: oxygen attracts the shared electrons more strongly than hydrogen, giving oxygen a partial negative charge and hydrogen a partial positive charge. This lets water molecules form hydrogen bonds with one another and with other polar substances.

Water dissolves ions and other polar molecules, so blood plasma and plant sap can carry solutes. Its cohesion helps maintain continuous water columns, while its high specific heat capacity makes temperature changes less abrupt.

Sodium ions do not travel as isolated crystals in plasma; they are surrounded by oriented water molecules. In xylem, hydrogen bonding between water molecules helps a transpiration stream remain continuous when evaporation pulls water upwards.

Water is not a universal solvent: non-polar lipids do not dissolve readily. Polarity explains both transport of charged solutes and why membranes can separate aqueous compartments.

Monosaccharides are single sugars such as glucose, fructose and galactose. A disaccharide contains two monosaccharides joined by a glycosidic bond; a polysaccharide is a long chain of sugar units.

Maltose is glucose–glucose, sucrose is glucose–fructose and lactose is glucose–galactose. Starch contains amylose and branched amylopectin; glycogen is even more highly branched, making glucose release faster in animal cells.

Small sugars are soluble and readily transported, whereas starch and glycogen are compact, insoluble stores with little osmotic effect. Branching creates more chain ends for enzymes to remove glucose.

A plant can transport sucrose in phloem but store glucose units as starch. A liver cell stores glycogen so it can release glucose rapidly between meals without filling the cytoplasm with many separate sugar molecules.

Do not treat every polysaccharide as a fuel store: cellulose is also a glucose polymer, but its structure makes it a strong fibre rather than a readily digested reserve.

Benedict's reagent tests for reducing sugars: on heating, a blue solution changes through green, yellow and orange towards a brick-red precipitate as more copper(II) is reduced. Iodine solution turns blue-black when starch is present.

Use equal sample volumes, add the same reagent volume, heat Benedict's samples in a water bath for the same time, and include a water control. Compare the colour with a calibration series if estimating concentration.

A sample that stays blue in Benedict's but turns blue-black with iodine contains starch but no detectable reducing sugar under those conditions. Hydrolysing a non-reducing sugar first can reveal reducing products.

The colour is evidence of a chemical reaction, not a direct count of molecules. A semi-quantitative result is stronger when controls, repeats and a reference colour scale are used.

A negative Benedict's test means ‘not detected at this sensitivity’, not ‘no carbohydrate’. Heating, reagent volumes and subjective colour matching affect the conclusion.

A condensation reaction joins two monosaccharides while releasing water. The new covalent link is a glycosidic bond; hydrolysis adds water to break that bond and release smaller sugars.

The bond name records the carbon positions involved. For example, maltose has a 1,4 glycosidic bond between two glucose molecules, while sucrose joins glucose and fructose through a 1,2 link.

The same monomers can make molecules with different properties because bond position and orientation change branching, shape and enzyme access. Hydrolysis is therefore a controlled way to release absorbable sugars.

Digestive enzymes hydrolyse a disaccharide into monosaccharides before absorption. In a plant, repeated condensation builds a polysaccharide store and releases water at each bond formed.

Condensation forms the bond; hydrolysis breaks it. Do not say that a glycosidic bond is ‘a sugar molecule’ or assume all glucose polymers have the same structure.

A triglyceride forms when glycerol reacts with three fatty acids in condensation reactions, creating three ester bonds and releasing three water molecules. Its hydrocarbon tails store substantial chemical energy.

A saturated fatty acid has no carbon–carbon double bond; an unsaturated fatty acid has one or more. Double bonds introduce bends, so unsaturated tails usually pack less tightly and have lower melting points.

Long reduced hydrocarbon chains contain many bonds that can be oxidised, giving lipids a high energy value per gram. Their insolubility also makes them compact stores with little osmotic effect.

A fat rich in saturated tails tends to be solid at room temperature, whereas an oil rich in cis-unsaturated tails is more likely to remain liquid. The physical state reflects tail packing, not simply the word ‘lipid’.

One double bond does not make a lipid ‘healthy’ or determine every biological effect. Separate molecular structure, physical state and health evidence.

Diffusion is effective over short distances but becomes too slow when an organism is large or metabolically active. A circulatory system moves substances in bulk between exchange surfaces and tissues.

A pump maintains a pressure gradient and vessels provide a controlled route. The heart sends deoxygenated blood to the lungs and oxygenated blood to body tissues in a double circulation, keeping exchange gradients steep.

An active muscle has a high oxygen demand. Blood flow delivers oxygenated blood close to the cells and removes carbon dioxide, while diffusion completes the final short distance across capillary walls and tissue fluid.

The circulatory system does not replace diffusion: gases and solutes still cross exchange surfaces by diffusion or transport processes. Its role is to shorten effective transport distances and refresh gradients.

Arteries carry blood away from the heart under high pressure; veins return it at lower pressure; capillaries bring blood close to cells. The wall and lumen of each vessel suit its job.

Arteries have thick elastic and muscular walls to withstand and smooth pressure pulses. Veins have thinner walls, a wider lumen and valves to prevent backflow. Capillaries have a one-cell-thick wall and narrow lumen, slowing cells so exchange distances stay short.

A pulse can be felt in an artery because ventricular pressure stretches its elastic wall. A leg vein relies on valves and skeletal-muscle contractions to move blood back towards the heart against gravity.

Capillary branching creates a large exchange area; slow flow and a thin barrier allow oxygen, glucose and wastes to diffuse between blood and tissue fluid.

Arteries and veins are named by direction relative to the heart, not by oxygen content: the pulmonary artery carries deoxygenated blood and the pulmonary vein carries oxygenated blood.

One cardiac cycle alternates atrial systole, ventricular systole and diastole. Pressure changes caused by contraction and relaxation open or close valves, so blood moves in one direction.

During atrial systole, atria push blood into relaxed ventricles. During ventricular systole, atrioventricular valves close and semilunar valves open as ventricular pressure rises. During diastole, ventricles relax and refill when their pressure falls.

If ventricular pressure becomes greater than atrial pressure, the atrioventricular valve closes; if it becomes greater than arterial pressure, the semilunar valve opens. Valve movement follows pressure, not a separate command.

The sequence keeps oxygen-poor and oxygen-rich blood in the correct circuits and gives the heart time to fill between contractions.

Systole means contraction and diastole means relaxation; do not label a phase only by whether blood is entering or leaving, because pressure and valve state determine the flow.

Haemoglobin is a globular protein with four subunits, each able to bind oxygen reversibly. The percentage saturation curve is sigmoid because binding at one site affects the affinity of the remaining sites.

In the lungs, high oxygen partial pressure loads haemoglobin. In respiring tissues, lower oxygen pressure and higher carbon dioxide promote unloading, so oxygen is delivered where demand is greatest.

A working muscle produces more carbon dioxide and heat. The dissociation curve shifts right, meaning haemoglobin reaches a lower saturation at the same oxygen pressure and releases more oxygen.

The Bohr effect links carbon dioxide to oxygen delivery: carbon dioxide forms carbonic acid, lowering pH and reducing haemoglobin affinity. Foetal haemoglobin has a different affinity so oxygen can move from maternal blood to the foetus.

A right shift does not mean the blood contains no oxygen; it means affinity is lower at a given pressure. Read the curve and state the condition before inferring loading or unloading.

Atherosclerosis begins when the arterial endothelium is damaged. An inflammatory response attracts white blood cells, cholesterol-rich deposits and smooth-muscle changes, forming an atheroma in the artery wall.

Endothelial damage → inflammation → low-density lipoprotein enters the wall → macrophages form foam cells → plaque grows and narrows the lumen. A rough plaque can also encourage clot formation.

If a coronary artery lumen narrows, resistance to blood flow rises and cardiac muscle receives less oxygen. A plaque that ruptures may trigger a thrombus that blocks flow suddenly.

The disease links risk factors to a mechanism: high blood pressure can damage the endothelium, while smoking, diabetes and high LDL increase the likelihood of plaque development.

A risk factor raises probability rather than guaranteeing disease. Atherosclerosis is plaque formation in the artery wall; thrombosis is a clotting event that may follow it.

Damage to a blood vessel releases thromboplastin. In the presence of calcium ions, it helps convert soluble prothrombin into thrombin; thrombin converts soluble fibrinogen into insoluble fibrin.

Thrombin activates more clotting reactions and fibrin fibres form a mesh across the wound. Platelets become trapped, the mesh contracts and a clot reduces blood loss while tissue repair begins.

A cut exposes tissue and activates the cascade locally. The resulting fibrin network stays near the damaged vessel rather than turning all circulating fibrinogen into a body-wide clot.

The cascade amplifies a small trigger, but inhibitors and the intact endothelium limit clotting to the injury. If a clot forms inside an artery it can obstruct blood flow and cause thrombosis.

Prothrombin and fibrinogen are soluble plasma proteins; thrombin and fibrin are the active enzyme/product in the sequence. Do not reverse these pairs.

A risk factor is a characteristic associated with a higher probability of cardiovascular disease. Genetics, age, smoking, inactivity, diet and high blood pressure can alter risk, but none alone proves that an individual will develop disease.

Risk-factor data compare groups or exposures, often using relative risk or correlation. Confounding variables, sample selection and reverse causation can make a simple association misleading.

If smokers show a higher CVD rate than non-smokers, the result supports an association. To argue for causation, ask whether dose, timing, plausible mechanism and alternative explanations have been addressed.

Separate modifiable factors such as smoking and inactivity from non-modifiable factors such as age or inherited susceptibility. A prevention decision should weigh effect size, evidence quality and feasibility.

‘Causes’ is stronger than ‘is associated with’. A population trend does not predict an individual outcome, and reducing one risk factor does not remove every other source of risk.

Antioxidants can react with reactive molecules and may reduce oxidative damage. This gives a plausible link between diet and cardiovascular disease, but plausibility is not the same as demonstrated protection.

Oxidative damage can affect lipids and the arterial endothelium, yet CVD is also shaped by blood pressure, LDL, smoking, diabetes and activity. A single nutrient cannot be treated as an isolated cause.

A study may find that people who eat more fruit have lower CVD risk. The result could reflect antioxidants, fibre, lower saturated-fat intake or other lifestyle differences, so the design must address confounding.

Prefer evidence from controlled interventions or well-adjusted longitudinal studies over a single correlation. Report the strength and limits of the evidence before recommending a behaviour.

“Contains antioxidants” does not prove a food prevents CVD, and a supplement trial is not automatically equivalent to a whole-diet effect. Separate mechanism, association and outcome evidence.

To estimate vitamin C in a drink, use a reagent whose colour change is linked to the amount of vitamin C present, then compare the sample with standards or a measured titre. The endpoint must be defined before comparing samples.

Prepare a known vitamin-C standard series, keep reagent volume and sample volume consistent, test an unknown sample, repeat measurements and use the calibration relationship to estimate concentration. Protect vitamin C from unnecessary heat and oxidation.

A darker or later endpoint is only meaningful when the same conditions and endpoint rule were used. Replicates reveal random variation; a blank identifies colour from the drink rather than vitamin C.

If an orange drink decolourises more reagent than the diluted standard, first check dilution and endpoint consistency before concluding that it contains more vitamin C.

The practical estimates vitamin-C-equivalent reducing capacity under the chosen conditions; it does not prove that every antioxidant in the drink or its health effect has been measured.

Describe what the data show before explaining it: identify the population, units, trend and comparison. A correlation means two variables change together; it does not by itself show that one causes the disease.

Confounders such as age, income, activity or access to healthcare can influence both the risk factor and the outcome. Relative risk, absolute risk and sample size answer different questions.

If disease prevalence rises with smoking exposure, state the size and direction of the association, then ask whether dose, timing, biological mechanism and alternative explanations support a causal interpretation.

Use confidence intervals or statistical tests where supplied, avoid extrapolating beyond the population studied, and distinguish an individual prediction from a population estimate.

A statistically significant association can still be biased; a non-significant result does not prove no effect. “Linked to” and “causes” are not interchangeable.

Judge a study by asking who was sampled, how exposure and outcome were measured, whether comparison groups are appropriate, and whether the time sequence can support the claim. A large sample cannot rescue a biased design.

Check representativeness and sample size; define variables consistently; control or stratify confounders; use blinding or randomisation where possible; and report drop-outs and measurement uncertainty.

A questionnaire finding that diet and CVD are associated may suffer recall bias and self-selection. A prospective cohort with repeated measurements gives stronger temporal evidence but still cannot control every confounder.

Validity concerns whether the design supports the intended inference; reliability concerns consistency. Ethical limits may make a randomised exposure impossible, so conclusions should match the design.

An observational study can support an association without proving causation. Do not treat “peer reviewed” or “statistically significant” as substitutes for examining the method.

People often judge risk using vividness, familiarity and perceived control rather than the measured probability alone. Rare dramatic events can feel more likely than common gradual hazards.

Actual risk is estimated from population data and an agreed time frame; perceived risk is an individual judgement that can be shifted by media coverage, personal experience and trust in the source.

A person may fear a rare treatment side effect after seeing a news story but underestimate the cumulative CVD risk of smoking because it is familiar. The decision changes when absolute risk and comparison groups are made explicit.

Good communication does not simply replace perception with a number: it explains denominator, time horizon, uncertainty and the action that can change risk.

A perception is not “wrong” merely because it differs from an average statistic; context and values matter. But a decision should not confuse emotional salience with measured probability.

Cholesterol is transported in the blood in lipoproteins. LDL carries cholesterol towards tissues and is associated with atheroma risk when present in excess; HDL participates in reverse transport towards the liver.

A measured concentration is one risk indicator among many. Age, blood pressure, smoking, diabetes, genetics and treatment all affect the probability of CVD, and the relationship is population-based rather than deterministic.

Two people with the same LDL concentration can have different overall risk because their blood pressure, smoking status and family history differ. A treatment decision therefore uses a risk profile, not one number alone.

When interpreting data, identify the population, units, time period and whether the result is correlation or an intervention effect. Check uncertainty before claiming that changing one lipoprotein will remove risk.

HDL is not a guarantee of protection and LDL is not a diagnosis by itself. Avoid turning a continuous risk relationship into a binary label.

Reducing coronary heart disease (CHD) risk combines biological knowledge with an evidence-based decision: improve diet and activity, avoid smoking, manage blood pressure and interpret body-composition measures in context.

Body mass index and waist-to-hip ratio are screening indicators, not complete diagnoses. They can help identify groups for further assessment, but muscle mass, age, sex and ethnicity affect their meaning.

A high BMI may reflect muscle rather than excess adipose tissue; a central fat pattern may still signal metabolic risk. A sensible conclusion uses the measurement with blood pressure, lipids, family history and activity data.

When comparing an intervention, check whether risk-factor changes are measured over a relevant time and whether the study controls confounding. Translate the evidence into a proportionate recommendation rather than a guarantee.

“Lowers risk” is not “prevents disease”. Population evidence supports probability changes, not certainty for one individual.

Antihypertensives lower blood pressure; statins reduce cholesterol synthesis and LDL concentration; anticoagulants reduce clotting; platelet inhibitors reduce platelet aggregation. Each changes a different part of CVD risk.

A statin addresses long-term plaque risk, whereas an anticoagulant is relevant when unwanted clot formation is a concern. Beta blockers, vasodilators and diuretics lower pressure through different mechanisms.

A patient with high blood pressure and a high LDL concentration may need a different combination from a patient with an existing thrombus. Treatment choice depends on indication, benefit, contraindication and monitoring.

The same disease label can involve atherosclerosis, thrombosis or both. Matching mechanism to pathology prevents treating every cardiovascular problem as simply “high cholesterol”.

A drug reducing one risk factor does not erase all CVD risk, and benefits must be weighed against adverse effects. Do not infer a treatment recommendation from one measurement alone.